AL031985.3, LINC02870, and NRAV were reported to have participated in the prognostic signature of HCC (Chen et al., 2021; Xu et al., 2021; Zhang et al., 2021; Zhou et al., 2021). This evidence concerns the gene NRAV and hepatocellular carcinoma.